View in EDS PDF Full Text

Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

Saved in:
Bibliographic Details
Title: Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.
Authors: Solt, Laura A., Kumar, Naresh, Nuhant, Philippe, Yongjun Wang, Lauer, Janelle L., Jin Liu, Istrate, Monica A., Kamenecka, Theodore M., Roush, William R., Vidović, Dušica, Schürer, Stephan C., Jihong Xu, Wagoner, Gail, Drew, Paul D., Griffin, Patrick R., Burris, Thomas P.
Source: Nature. 4/28/2011, Vol. 472 Issue 7344, p491-494. 4p. 4 Graphs.
Subjects: Interleukins, Nuclear receptors (Biochemistry), Cytokines, Autoimmune disease treatment, Acetamide, Cell differentiation, T-cell receptor genes, Therapeutics
Abstract: T-helper cells that produce interleukin-17 (TH17 cells) are a recently identified CD4+ T-cell subset with characterized pathological roles in autoimmune diseases. The nuclear receptors retinoic-acid-receptor-related orphan receptors α and γt (RORα and RORγt, respectively) have indispensible roles in the development of this cell type. Here we present SR1001, a high-affinity synthetic ligand-the first in a new class of compound-that is specific to both RORα and RORγt and which inhibits TH17 cell differentiation and function. SR1001 binds specifically to the ligand-binding domains of RORα and RORγt, inducing a conformational change within the ligand-binding domain that encompasses the repositioning of helix 12 and leads to diminished affinity for co-activators and increased affinity for co-repressors, resulting in suppression of the receptors' transcriptional activity. SR1001 inhibited the development of murine TH17 cells, as demonstrated by inhibition of interleukin-17A gene expression and protein production. Furthermore, SR1001 inhibited the expression of cytokines when added to differentiated murine or human TH17 cells. Finally, SR1001 effectively suppressed the clinical severity of autoimmune disease in mice. Our data demonstrate the feasibility of targeting the orphan receptors RORα and RORγt to inhibit specifically TH17 cell differentiation and function, and indicate that this novel class of compound has potential utility in the treatment of autoimmune diseases. [ABSTRACT FROM AUTHOR]
Copyright of Nature is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 60243910
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Suppression of T<subscript>H</subscript>17 differentiation and autoimmunity by a synthetic ROR ligand.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Solt%2C+Laura+A%2E%22">Solt, Laura A.</searchLink><br /><searchLink fieldCode="AR" term="%22Kumar%2C+Naresh%22">Kumar, Naresh</searchLink><br /><searchLink fieldCode="AR" term="%22Nuhant%2C+Philippe%22">Nuhant, Philippe</searchLink><br /><searchLink fieldCode="AR" term="%22Yongjun+Wang%22">Yongjun Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Lauer%2C+Janelle+L%2E%22">Lauer, Janelle L.</searchLink><br /><searchLink fieldCode="AR" term="%22Jin+Liu%22">Jin Liu</searchLink><br /><searchLink fieldCode="AR" term="%22Istrate%2C+Monica+A%2E%22">Istrate, Monica A.</searchLink><br /><searchLink fieldCode="AR" term="%22Kamenecka%2C+Theodore+M%2E%22">Kamenecka, Theodore M.</searchLink><br /><searchLink fieldCode="AR" term="%22Roush%2C+William+R%2E%22">Roush, William R.</searchLink><br /><searchLink fieldCode="AR" term="%22Vidović%2C+Dušica%22">Vidović, Dušica</searchLink><br /><searchLink fieldCode="AR" term="%22Schürer%2C+Stephan+C%2E%22">Schürer, Stephan C.</searchLink><br /><searchLink fieldCode="AR" term="%22Jihong+Xu%22">Jihong Xu</searchLink><br /><searchLink fieldCode="AR" term="%22Wagoner%2C+Gail%22">Wagoner, Gail</searchLink><br /><searchLink fieldCode="AR" term="%22Drew%2C+Paul+D%2E%22">Drew, Paul D.</searchLink><br /><searchLink fieldCode="AR" term="%22Griffin%2C+Patrick+R%2E%22">Griffin, Patrick R.</searchLink><br /><searchLink fieldCode="AR" term="%22Burris%2C+Thomas+P%2E%22">Burris, Thomas P.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Nature%22">Nature</searchLink>. 4/28/2011, Vol. 472 Issue 7344, p491-494. 4p. 4 Graphs.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Interleukins%22">Interleukins</searchLink><br /><searchLink fieldCode="DE" term="%22Nuclear+receptors+%28Biochemistry%29%22">Nuclear receptors (Biochemistry)</searchLink><br /><searchLink fieldCode="DE" term="%22Cytokines%22">Cytokines</searchLink><br /><searchLink fieldCode="DE" term="%22Autoimmune+disease+treatment%22">Autoimmune disease treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Acetamide%22">Acetamide</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+differentiation%22">Cell differentiation</searchLink><br /><searchLink fieldCode="DE" term="%22T-cell+receptor+genes%22">T-cell receptor genes</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: T-helper cells that produce interleukin-17 (TH17 cells) are a recently identified CD4+ T-cell subset with characterized pathological roles in autoimmune diseases. The nuclear receptors retinoic-acid-receptor-related orphan receptors α and γt (RORα and RORγt, respectively) have indispensible roles in the development of this cell type. Here we present SR1001, a high-affinity synthetic ligand-the first in a new class of compound-that is specific to both RORα and RORγt and which inhibits TH17 cell differentiation and function. SR1001 binds specifically to the ligand-binding domains of RORα and RORγt, inducing a conformational change within the ligand-binding domain that encompasses the repositioning of helix 12 and leads to diminished affinity for co-activators and increased affinity for co-repressors, resulting in suppression of the receptors' transcriptional activity. SR1001 inhibited the development of murine TH17 cells, as demonstrated by inhibition of interleukin-17A gene expression and protein production. Furthermore, SR1001 inhibited the expression of cytokines when added to differentiated murine or human TH17 cells. Finally, SR1001 effectively suppressed the clinical severity of autoimmune disease in mice. Our data demonstrate the feasibility of targeting the orphan receptors RORα and RORγt to inhibit specifically TH17 cell differentiation and function, and indicate that this novel class of compound has potential utility in the treatment of autoimmune diseases. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Nature is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=60243910
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/nature10075
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 491
    Subjects:
      – SubjectFull: Interleukins
        Type: general
      – SubjectFull: Nuclear receptors (Biochemistry)
        Type: general
      – SubjectFull: Cytokines
        Type: general
      – SubjectFull: Autoimmune disease treatment
        Type: general
      – SubjectFull: Acetamide
        Type: general
      – SubjectFull: Cell differentiation
        Type: general
      – SubjectFull: T-cell receptor genes
        Type: general
      – SubjectFull: Therapeutics
        Type: general
    Titles:
      – TitleFull: Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Solt, Laura A.
      – PersonEntity:
          Name:
            NameFull: Kumar, Naresh
      – PersonEntity:
          Name:
            NameFull: Nuhant, Philippe
      – PersonEntity:
          Name:
            NameFull: Yongjun Wang
      – PersonEntity:
          Name:
            NameFull: Lauer, Janelle L.
      – PersonEntity:
          Name:
            NameFull: Jin Liu
      – PersonEntity:
          Name:
            NameFull: Istrate, Monica A.
      – PersonEntity:
          Name:
            NameFull: Kamenecka, Theodore M.
      – PersonEntity:
          Name:
            NameFull: Roush, William R.
      – PersonEntity:
          Name:
            NameFull: Vidović, Dušica
      – PersonEntity:
          Name:
            NameFull: Schürer, Stephan C.
      – PersonEntity:
          Name:
            NameFull: Jihong Xu
      – PersonEntity:
          Name:
            NameFull: Wagoner, Gail
      – PersonEntity:
          Name:
            NameFull: Drew, Paul D.
      – PersonEntity:
          Name:
            NameFull: Griffin, Patrick R.
      – PersonEntity:
          Name:
            NameFull: Burris, Thomas P.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 04
              Text: 4/28/2011
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-print
              Value: 00280836
          Numbering:
            – Type: volume
              Value: 472
            – Type: issue
              Value: 7344
          Titles:
            – TitleFull: Nature
              Type: main
ResultId 1